The federal government has been ordered to reassess its 2022 approval of a popular weed-killer after a Federal Court judge ruled this week the original approval was unreasonable.
In a decision issued Tuesday, Justice Russell Zinn gave Health Canada six months to reassess the health risks of glyphosate—the most heavily-used pesticide ingredient in Canada—after the agency failed to show it considered new scientific evidence identifying new or elevated risks associated with the herbicide when it renewed the registration for a product containing it.
